Closely-held CellAegis Devices has appointed Brian Fielding as CFO and Hans Custers as VP of sales and marketing for Europe.
The appointments are intended to support global commercialization of the company’s autoRIC device, which automates the delivery of Remote Ischemic Conditioning (RIC).
In an executive management career that spans more than 30 years, Mr. Fielding has held numerous C-level positions with a broad portfolio of both development-stage and commercial life science organizations. Most recently, Mr. Fielding served as CFO of Therapure BioPharma.
Mr. Custers brings over three decades of healthcare sales, marketing, distribution, and product development experience to the company. He has held senior positions with several medical device and start-up companies, including Terumo Europe, CD4MD, and CryoCath/Medtronic. Mr. Custers will be focused on the development and execution of a comprehensive European commercial strategy for the autoRIC device, which is CE Marked.
“We are approaching a stage of anticipated rapid global growth,” Rocky Ganske, CEO, said in a statement. “With the additions of Brian and Hans, we now have a leadership team optimized to support our business in automated RIC and capable of maximizing the significant cardiovascular market opportunity that we see ahead of us.”
